Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Policosanol: a new treatment for cardiovascular disease?

Janikula M.

Altern Med Rev. 2002 Jun;7(3):203-17. Review.

2.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
3.

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.

Castaño G, Más R, Fernández JC, Illnait J, Fernández L, Alvarez E.

J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M186-92.

PMID:
11253161
4.

Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

Gouni-Berthold I, Berthold HK.

Am Heart J. 2002 Feb;143(2):356-65. Review.

PMID:
11835043
5.

Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.

Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.

Int J Clin Pharmacol Res. 2001;21(1):31-41.

PMID:
11708573
6.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
7.

Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.

Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.

Int J Clin Pharmacol Res. 2002;22(3-4):89-99.

PMID:
12837046
8.

Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.

Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.

Int J Clin Pharmacol Res. 1999;19(4):117-27.

PMID:
10939029
9.

Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.

Dulin MF, Hatcher LF, Sasser HC, Barringer TA.

Am J Clin Nutr. 2006 Dec;84(6):1543-8.

PMID:
17158441
10.

Effects of policosanol on postmenopausal women with type II hypercholesterolemia.

Castaño G, Más R, Fernández L, Fernández JC, Illnait J, López LE, Alvarez E.

Gynecol Endocrinol. 2000 Jun;14(3):187-95.

PMID:
10923280
11.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
12.

Treatment of hypercholesterolemia in NIDDM with policosanol.

Torres O, Agramonte AJ, Illnait J, Más Ferreiro R, Fernández L, Fernández JC.

Diabetes Care. 1995 Mar;18(3):393-7.

PMID:
7555484
13.

A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.

Alcocer L, Fernández L, Campos E, Más R.

Int J Tissue React. 1999;21(3):85-92.

PMID:
10645516
14.
15.

A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.

Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, Fernández J, Mesa M.

Drugs Exp Clin Res. 2005;31 Suppl:31-44.

PMID:
16444910
16.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175
17.

Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.

Francini-Pesenti F, Beltramolli D, Dall'acqua S, Brocadello F.

Phytother Res. 2008 Mar;22(3):318-22. doi: 10.1002/ptr.2315.

PMID:
18167048
18.

[Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].

Prat H, Román O, Pino E.

Rev Med Chil. 1999 Mar;127(3):286-94. Spanish.

PMID:
10436712
19.

Concomitant use of policosanol and beta-blockers in older patients.

Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.

Int J Clin Pharmacol Res. 2004;24(2-3):65-77.

PMID:
15689053
20.

Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I.

JAMA. 2006 May 17;295(19):2262-9.

PMID:
16705107

Supplemental Content

Support Center